Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ilsung Pharmaceutical is a long-standing South Korean pharmaceutical company that specializes in the production and marketing of specialized medicines, including antibiotics, anesthetics, and contrast media. Founded in 1954, the company has built a strong reputation through long-term collaborations with global pharmaceutical leaders such as GSK and Bracco. Ilsung operates advanced manufacturing facilities that comply with international GMP standards, ensuring the delivery of high-quality therapeutic and diagnostic agents. The company's portfolio includes well-known brands like Augmentin and Suprane, serving critical needs in hospitals and clinics across Korea. Ilsung is publicly traded on the Korea Exchange and remains focused on expanding its presence in the domestic healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ilsung Pharmaceutical.